Hitachi High-Tech and Invivoscribe Partner to Advance Molecular Diagnostics

TOKYO, May 10, 2022 – (JCN Newswire via SEAPRWire.com) – Hitachi High-Tech Corporation has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc., a global provider of blood cancer testing kits and services, by undertaking a minority investment-based, third-party allotment of shares. The Partnership aims to accelerate the molecular diagnostics(1) and precision medicine businesses […]

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

– EBITDA grew 47% for 12 months ended 31 Dec 2021– Proposed listing of 49%-owned Acumen Diagnostics on NASDAQ will enhance AOXIN’s shareholder value– Growth trend in revenue expected to continue as COVID-19 situation in China improves SINGAPORE, Feb 23, 2022 – (ACN Newswire) – Catalist listed Aoxin Q&M Dental Limited (“Aoxin” or “the Group”), today announced a 20.8% […]

Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide

SINGAPORE, Dec 16, 2021 – (ACN Newswire via SEAPRWire.com) – Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. (“Acumen Diagnostics” or the “Company”), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited (“Q&M Dental”) and 49% owned by Aoxin Q&M Dental Group Limited (“Aoxin Q&M Dental”), today announced that it has been granted a […]

Acumen Diagnostics’ PCR capabilities to tackle Omicron COVID-19 variant

SINGAPORE, Dec 3, 2021 – (ACN Newswire via SEAPRWire.com) – Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. (“Acumen Diagnostics” or the “Company”), a 51% owned subsidiary of Q&M Dental Group (Singapore) and 49% owned by Aoxin Q&M Dental, today announced that its proprietary, locally-manufactured polymerase chain reaction (“PCR”) test kits Acu-Corona 2.0 and Acu-Corona […]

ACT Genomics Completes Acquisition of MC Diagnostics

HONG KONG, Jul 6, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Co. Ltd. (“ACT Genomics” or “the Group”) has completed the acquisition of MC Diagnostics Ltd. (“MCD”), a specialist molecular diagnostic company based in the United Kingdom, which marks the Group’s entry into the European precision medicine market. MCD machine in operation Founded […]